Iovance Biotherapeutics (IOVA) Change in Cash (2010 - 2026)
Iovance Biotherapeutics (IOVA) posted quarterly Change in Cash of $33.4 million for Q1 2026, down 40.28% year-over-year from $56.0 million in Q1 2025, and up 574.37% quarter-over-quarter from $5.0 million in Q4 2025.
Iovance Biotherapeutics (IOVA) Change in Cash (2010 - 2026) Analysis & Trends
Iovance Biotherapeutics (IOVA) has reported Change in Cash for 17 consecutive years, with $33.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Cash fell 40.28% year-over-year to $33.4 million; the TTM figure through Mar 2026 stood at $24.5 million (down 34.68% YoY), while the FY2025 annual figure was $47.0 million, up 179.31% from the prior year.
- Change in Cash improved to $33.4 million in Q1 2026 per IOVA's latest filing, from $5.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $311.8 million in Q1 2023 and bottomed at -$253.5 million in Q2 2023.
- Historically, Change in Cash has averaged $7.0 million across 5 years, with a median of $14.1 million in 2022.
- On a YoY basis, Change in Cash climbed as much as 2106.16% in 2023 and fell as far as 1678.2% in 2023.
- Iovance Biotherapeutics' Change in Cash stood at $113.4 million in 2022, then tumbled by 234.81% to -$152.8 million in 2023, then surged by 68.27% to -$48.5 million in 2024, then surged by 110.23% to $5.0 million in 2025, then soared by 574.37% to $33.4 million in 2026.
- Business Quant data shows IOVA's Change in Cash at $33.4 million in Q1 2026, $5.0 million in Q4 2025, and $25.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Iovance Biotherapeutics | 3.16 Bn | 2.86 Bn | 55.72 Mn | -85.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -85.73 Mn |
| Mar 31, 2026 | 33.44 Mn |
| Dec 31, 2025 | 4.96 Mn |
| Sep 30, 2025 | 25.69 Mn |
| Jun 30, 2025 | -39.64 Mn |
| Mar 31, 2025 | 56.00 Mn |
| Dec 31, 2024 | -48.49 Mn |
| Sep 30, 2024 | -64.57 Mn |
| Jun 30, 2024 | 94.49 Mn |
| Mar 31, 2024 | -40.70 Mn |
| Dec 31, 2023 | -152.83 Mn |
| Sep 30, 2023 | 37.71 Mn |
| Jun 30, 2023 | -253.47 Mn |
| Mar 31, 2023 | 311.75 Mn |
| Dec 31, 2022 | 113.37 Mn |
| Sep 30, 2022 | 10.29 Mn |
| Jun 30, 2022 | 16.06 Mn |
| Mar 31, 2022 | 14.13 Mn |
| Dec 31, 2021 | 19.64 Mn |
| Sep 30, 2021 | -24.17 Mn |